How big is the North America Anticoccidial Drugs Market?

The North America Anticoccidial Drugs Market size is expected to reach USD 537.19 million in 2024 and grow at a CAGR of 4.63% to reach USD 673.61 million by 2029. Read More

What is the current North America Anticoccidial Drugs Market size?

In 2024, the North America Anticoccidial Drugs Market size is expected to reach USD 537.19 million. Read More

Who are the key players in North America Anticoccidial Drugs Market?

Phibro Animal Health Corporation, Huvepharma, Zoetis Animal Healthcare, Elanco. and Boehringer Ingelheim GmbH are the major companies operating in the North America Anticoccidial Drugs Market. Read More

What years does this North America Anticoccidial Drugs Market cover, and what was the market size in 2023?

In 2023, the North America Anticoccidial Drugs Market size was estimated at USD 513.42 million. The report covers the North America Anticoccidial Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Anticoccidial Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

North America Anticoccidial Drugs Market Share

Statistics for the 2023 & 2024 North America Anticoccidial Drugs market share, created by Mordor Intelligence™ Industry Reports. North America Anticoccidial Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of North America Anticoccidial Drugs Industry

The North America Anticoccidial Drugs Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Zoetis Animal Healthcare, Phibro Animal Health Corporation, Huvepharma, Elanco, Ceva Animal Health Inc., MSD Animal Health, Vetoquinol SA, Impextraco NV.